3 | SEC Filings Hub

Filing metadata

Accession number: 0000921895-22-002106
Form type: Form 3
Filer: 4D Molecular Therapeutics, Inc.
CIK: CIK 1650648
Filed: Jun 27, 2022
Reporting period: Jun 16, 2022
Description: Initial ownership

Documents

0000921895-22-002106-index.htm

Complete submission

0000921895-22-002106.txt

directory listing

Filed by

4D Molecular Therapeutics, Inc.